Traditionally, clinicopathological characteristics, including age at diagnosis, tumor size, lymph node metastasis, histologic grade, and ER, PR, and HER2 status, have been known as important prognostic factors in early-stage breast cancer (1). This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.